The Big Commercialisation Survey
What are the key commercialisation challenges associated with bringing a cell and/or gene therapy to commercial scale?
This industry-wide survey – developed in partnership with Cognate BioServices – aims to understand the commercialisation challenges you’re facing when bringing a cell and gene therapy (CGT) product through clinical development to commercial scale, as well as to provide you with a benchmark against the wider industry.
Plus, watch this space for an infographic of the results!
This survey has now closed – thank you to everyone who participated. Watch this space for an infographic with the results.